March 22, 2016
The Brooklyn federal judge handling criminal allegations against Martin Shkreli and former Kaye Scholer LLP partner Evan Greebel stayed an overlapping civil fraud case Tuesday, rejecting the defendants' efforts to force prosecutors to litigate alongside the U.S. Securities and Exchange Commission but offering to set a criminal trial date soon.
February 19, 2016
New York federal prosecutors say they are concerned about possible witness intimidation by former Turing Pharmaceuticals CEO Martin Shkreli, who is accused of running a securities fraud scheme, based on his record of purportedly intimidating behavior.
February 08, 2016
The Kaye Scholer LLP partner charged with securities fraud alongside pharma bad boy Martin Shkreli has enlisted a Gibson Dunn partner who was the lead prosecutor in Rajat Gupta's insider trading trial and who also helped convict hedge fund boss Raj Rajaratnam, according to New York federal court documents.
February 03, 2016
Martin Shkreli has agreed to stop mouthing off and wants to fight against criminal securities fraud charges against him in court, his new lawyer Benjamin Brafman said Wednesday in Brooklyn, adding that the pharma bad boy with a shrinking bank account will invoke his right not to testify if called before the U.S. Congress on Thursday.
February 02, 2016
Defense attorney Benjamin Brafman said Tuesday he will be taking over for Arnold & Porter LLP in defending Martin Shkreli against allegations of securities fraud in New York federal court, making the pharmaceutical executive the newest in a long line of famous and infamous clients.
January 19, 2016
Martin Shkreli, the pharmaceutical executive who drew national scorn for a drug price hike and was later indicted on securities fraud charges, has dropped Arnold & Porter LLP as defense counsel in the criminal case, according to a Monday filing in New York federal court.
January 07, 2016
Martin Shkreli's $45 million brokerage account was put on lockdown Thursday by the New York federal judge overseeing the securities fraud case against the young ex-CEO.
January 04, 2016
A Delaware bankruptcy judge has given troubled pharmaceutical company KaloBios emergency permission to pay its employees, but barred any of that money going to fired CEO Martin Shkreli, who was charged with securities fraud two weeks before the company hit Chapter 11.
December 22, 2015
A Kaye Scholer LLP partner who was arrested alongside infamous pharma CEO Martin Shkreli in connection with Shkreli's securities-fraud charges was given court permission Monday to take a family vacation to Mexico, according to the firm, as it investigates him internally.